Relationship between effluent levels of β2-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 4, 2007, Pages 296-300

  Minami, Satoshi ^a   Hora, Kazuhiko ^a   Kamijo, Yuji ^a   Higuchi, Makoto ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 microglobulin; Biocompatibility; Continuous ambulatory peritoneal dialysis; Icodextrin

Indexed keywords

BETA 2 MICROGLOBULIN; GELATINASE A; GLUCOSE; HYALURONIC ACID; ICODEXTRIN; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE MARKER; FEMALE; HUMAN; MALE; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TREATMENT DURATION;

ADULT; AGED; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; FEMALE; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM;

EID: 34547176159     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00493.x     Document Type: Article

References (17)

1. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996 50 : 979 86.
2. Araujo Teixeira MR, Pecoits-Filho RF, Romao Junior JE et al. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test. Perit Dial Int 2002 22 : 229 33.
3. Opatrna S, Opatrny K Racek J et al. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance. Perit Dial Int 2003 23 : 89 91.
4. Lilaj T, Dittrich E, Puttinger H et al. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results. Am J Kidney Dis 2001 38 : 118 26.
5. Moriishi M, Kawanishi H, Watanabe H et al. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution. Adv Perit Dial 2004 20 : 166 9.
6. Parikova A, Zweers MM, Struijk DG et al. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial 2003 19 : 186 90.
7. Martikainen TA, Teppo AM, Gronhagen-Riska C et al. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005 25 : 453 60.
8. Moriishi M, Kawanishi H, Watanabe H et al. Effect of [icodextrin-based peritoneal dialysis solution on peritoneal m]embrane. Adv Perit Dial 2005 21 : 21 4.
9. Moriishi M, Kawanishi H, Tsuchiya S et al. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients. Adv Perit Dial 2006 22 : 24 8.
10. Bajo MA, Selgas R, Castro MA et al. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo. Perit Dial Int 2000 20 : 742 7.
11. Posthuma N, Verbrugh HA, Donker AJ et al. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years. Perit Dial Int 2000 20 : 174 80.
12. Cooker LA, Holmes CJ, Hoff CM. Biocompatibility of icodextrin. Kidney Int Suppl 2002 81 : S34 45.
13. Garcia-Lopez E, Lindholm B, Tranaeus A. Biocompatibility of new peritoneal dialysis solutions: clinical experience. Perit Dial Int 2000 20 : S48 56.
14. Hirahara I, Umeyama K, Urakami K et al. Serial analysis of matrix metalloproteinase-2 in dialysate of rat sclerosing peritonitis models. Clin Exp Nephrol 2001 5 : 103 8.
15. Hirahara I, Umeyama K, Shofuda K et al. Increase of matrix metalloproteinase-2 in dialysate of rat sclerosing encapsulating peritonitis model. Nephrology 2002 7 : 161 9.
16. Hirahara I, Ogawa Y, Kusano E, Asano Y. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 2004 19 : 1732 41.
17. Numata M, Nakayama M, Nimura S et al. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 2003 23 : 116 22.